Home › Funds › Bridgewater Associates › HCA
Bridgewater Associates position in HCA
HCA HEALTHCARE INC · Health Care
Bridgewater Associates reported holding 202,141 shares of HCA (HCA HEALTHCARE INC) in its Q3 2026 13F filing — a position valued at US$86.3M, representing 0.38% of its reported portfolio and ranking #49 among its reported holdings. Bridgewater Associates has disclosed HCA holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Bridgewater Associates's HCA position evolved
Bridgewater Associates first disclosed a stake in HCA in Q3 2021 at 341,375 shares (US$82.9M). The position peaked in Q2 2025 at 406,706 shares, worth US$155.8M. Across 21 filings, Bridgewater Associates increased the stake 6 time(s), trimmed it 14 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 202,141 shares valued at US$86.3M — a reduction of -1,063 shares quarter over quarter.. Notable position changes include a 27% increase in Q2 2022 (shares rose 9% over the following quarter), a 88% increase in Q4 2024 (shares rose 15% over the following quarter), a 47% trim in Q1 2026 (shares fell 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 341.38K | $82.86M | New |
| Q4 2021 | 312.87K | $80.38M | Reduce |
| Q1 2022 | 389.35K | $97.58M | Add |
| Q2 2022 | 495.52K | $83.28M | Add |
| Q3 2022 | 372.04K | $68.38M | Reduce |
| Q4 2022 | 345.45K | $82.90M | Reduce |
| Q1 2023 | 340.74K | $89.85M | Reduce |
| Q2 2023 | 302.74K | $91.88M | Reduce |
| Q3 2023 | 375.71K | $92.42M | Add |
| Q4 2023 | 426.28K | $115.38M | Add |
| Q1 2024 | 346.31K | $115.51M | Reduce |
| Q2 2024 | 295.90K | $95.07M | Reduce |
| Q3 2024 | 250.04K | $101.62M | Reduce |
| Q4 2024 | 470.55K | $141.24M | Add |
| Q1 2025 | 428.73K | $148.15M | Reduce |
| Q2 2025 | 406.71K | $155.81M | Reduce |
| Q3 2025 | 340.56K | $145.15M | Reduce |
| Q4 2025 | 329.31K | $153.74M | Reduce |
| Q1 2026 | 173.80K | $82.25M | Reduce |
| Q2 2026 | 203.20K | $79.23M | Add |
| Q3 2026 | 202.14K | $86.26M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HCA and 13F data
HCA (HCA HEALTHCARE INC) is a Health Care company. 24 other funds we track also report a position in HCA — the largest reported positions include Sanders Capital, LLC (US$3.75B), First Eagle Investment Management (US$1.39B), Arrowstreet Capital (US$851.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HCA
- Sanders Capital, LLC 8.79M sh · $3.75B · Q3 2026
- First Eagle Investment Management 3.27M sh · $1.39B · Q3 2026
- Arrowstreet Capital 2.00M sh · $851.78M · Q3 2026
- NORDEA INVESTMENT MANAGEMENT AB 1.40M sh · $602.17M · Q3 2026
- Darsana Capital Partners LP 1.10M sh · $469.41M · Q3 2026
More on Bridgewater Associates
FAQ
How long has Bridgewater Associates held HCA?
Bridgewater Associates has disclosed HCA holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
What is Bridgewater Associates's current position in HCA?
As of Q3 2026, Bridgewater Associates holds 202.14K shares of HCA (HCA HEALTHCARE INC), valued at $86.26M, representing 0.38% of its reported portfolio and ranking #49.
Has Bridgewater Associates been buying or selling HCA?
In the latest 13F filing (Q3 2026), Bridgewater Associates reduced its position in HCA. The position peaked in Q2 2025 at 406.71K shares.
Which other funds hold HCA?
Other major institutional holders of HCA include Sanders Capital, LLC, First Eagle Investment Management, Arrowstreet Capital, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.